分类： health

Chinese researchers have pioneered a groundbreaking biomimetic platform that significantly enhances the effectiveness of CAR-T therapy for leukemia patients. This innovative approach, described as ‘molecular double-sided tape,’ addresses the critical challenge of cancer relapse that affects over 50% of patients following conventional treatment.

The technology, detailed in the prestigious journal Cell, centers on the discovery that CD71—a protein responsible for iron transport—shows consistently high expression across various leukemia types and disease stages. Leveraging this biological feature, scientists from the Chinese Academy of Sciences’ Institute of Process Engineering developed the Ferritin Aggregation Cell Engager (FACE) platform through precisely controlled solvent-induced self-assembly.

Unlike traditional methods that require complex genetic reengineering of CAR-T cells, the FACE platform integrates seamlessly with existing treatment protocols. During the 30-minute preparation phase, FACE anchors to CAR-T cells via CD71 receptors. Upon administration, it simultaneously attaches to leukemia cells, creating a reinforced connection that dramatically improves cancer cell recognition and elimination.

In preclinical trials using patient-derived leukemia models, the technology demonstrated remarkable efficacy. The FACE-enhanced therapy achieved equivalent therapeutic outcomes using only 20% of the conventional CAR-T cell dosage while substantially reducing adverse effects. Most notably, the platform remained effective even when cancer antigens dropped below 10% of normal levels—a condition that typically renders leukemia cells undetectable to standard CAR-T cells.

The researchers further advanced the technology by developing a drug-loaded variant that delivers chemotherapy directly to cancer cells. This combined approach proves particularly effective against antigen-negative escapees that commonly evade conventional treatments.

Professor Wei Wei, corresponding author of the study, emphasized the clinical advantages: ‘Our FACE platform utilizes endogenous proteins and FDA-approved polymer derivatives, manufactured through a simple, scalable process. It integrates seamlessly into existing CAR-T workflows without additional genetic engineering.’

The technology has been validated across multiple leukemia subtypes and treatment-resistant scenarios using both mouse models and human patient samples. The research team has additionally established an efficacy database and AI-powered predictive framework to support clinical translation and treatment optimization.

Peer reviewers at Cell have endorsed the approach as ‘a promising translational strategy’ with potential applications across various blood cancers, highlighting its adaptability to diverse clinical settings and capacity to address leukemia antigen variability.

China is embarking on a comprehensive revision of its national food safety standards, prioritizing premade dishes, pesticide residue testing, and cold-chain transportation protocols. The State Council’s Food Safety Office announced this accelerated regulatory modernization effort on March 12, 2026, as part of a broader update to the country’s food safety legislation.

The initiative establishes enhanced cross-departmental coordination mechanisms to facilitate joint inspections and enforcement operations. Key focus areas include school cafeteria safety, food delivery service compliance, and preventing unauthorized food additive usage. The office will implement both regular and targeted crackdowns to address persistent public concerns regarding food safety violations.

Regulatory scrutiny will intensify across critical sectors including agricultural production, storage logistics, e-commerce food sales, and import controls. Authorities will enforce a zero-tolerance policy toward violations, applying stringent penalties for non-compliance. This approach aims to create robust regulatory frameworks grounded in comprehensively updated safety standards.

Addressing particular concerns about school nutrition, the program will expand technological integration through kitchen livestreaming systems to increase transparency in food preparation areas. Additional measures include strengthening collective procurement systems for school food supplies and implementing regular joint inspections to prevent substandard ingredients from entering educational institutions.

The regulatory enhancement strategy also involves improving inspection precision and proactively identifying potential risks before they escalate into public health concerns. This preemptive approach represents a shift toward more sophisticated food safety management systems.

This initiative follows the National Health Commission’s February release of draft national standards specifically addressing the rapidly expanding premade food industry, indicating coordinated efforts across government agencies to modernize China’s food safety ecosystem.

Tianjin has become home to an innovative wellness destination that seamlessly merges traditional Chinese medicine with contemporary consumer culture. Da Ren Tang, a century-old TCM establishment, has launched a groundbreaking wellness center that integrates medical services with retail offerings, featuring an array of TCM-infused food and beverage products that are capturing public imagination.

The facility represents a strategic evolution in traditional medicine presentation, offering patrons both healthcare consultations and unique culinary experiences. Among the most popular items are herbal breads incorporating astragalus root and specially formulated coffee beverages enhanced with ginseng extracts. The center also markets wellness accessories including medicinal bracelets and aromatic sachets designed for modern lifestyles.

This novel approach has particularly resonated with younger demographics who are discovering TCM through social media platforms. Egyptian student Hassan Sameh Hassan Elsayed from Tianjin University visited after encountering online content about Chinese wellness practices. His experience transformed his perception of TCM from something ‘ancient and mysterious’ to a dynamic field embracing modern applications beyond traditional acupuncture and herbal decoctions.

Center management notes that while older generations remain core clients, youth engagement has surged dramatically. Many young visitors specifically seek out TCM accessories they’ve discovered through digital channels, frequently documenting and sharing their experiences online. This organic social media presence has established the venue as a popular destination within Tianjin’s wellness tourism circuit.

Local resident Cheng, who frequents the establishment, confirms that these TCM-infused products have integrated into daily routines for community members. The center’s strategic placement adjacent to a traditional Chinese medicine hospital further enhances its credibility, allowing visitors to transition seamlessly between retail experiences and professional medical consultations.

This innovative model demonstrates how traditional healing practices can adapt to contemporary consumer preferences while maintaining therapeutic integrity, potentially setting a new standard for wellness tourism nationwide.

China’s healthcare system is gaining international recognition through groundbreaking surgical achievements and growing medical tourism. A recent case at Chongqing Medical University’s First Affiliated Hospital demonstrates this transformation, where Spanish tourist Juan received life-saving robotic surgery for a severe pelvic fracture using domestically developed technology.

The 30-year-old patient suffered critical injuries during a trip to Sichuan province in January. Under the leadership of Dr. Shui Wei, deputy director of orthopedics, a multidisciplinary team performed a 90-minute procedure using China’s innovative orthopedic surgical robot system. The technology enabled minimally invasive surgery with remarkably small incisions—just 7 centimeters in front and two 2-millimeter wounds in the back—compared to traditional approaches requiring much larger openings.

Juan reported an exceptionally positive experience, noting rapid recovery that allowed him to sit up within three days and discharge after just five days. Dr. Shui projected full recovery within months, potentially enabling a return to extreme sports with proper rehabilitation.

This case exemplifies China’s broader healthcare evolution. Where citizens once sought treatment abroad, China now attracts international patients through what experts term ‘reverse medical tourism.’ British influencer Amie’s experience highlights this shift—after waiting two years for treatment in the UK, she completed entire medical procedures in China within 13 days at approximately one-tenth the cost.

Official data from the National Health Commission reveals staggering growth: key hospitals handled 1.28 million international visits in 2025, representing a 73.6% increase from three years prior, with European and American patients doubling. Medical institutions are responding by establishing specialized international clinics, enhancing bilingual services, and implementing direct billing with global health insurers.

China’s combination of surgical innovation, treatment efficiency, cost effectiveness, and accessibility is positioning the nation as an emerging powerhouse in global healthcare services.

National political advisers have committed to accelerating China’s healthcare modernization following a pivotal meeting with President Xi Jinping in Beijing. The engagement, which occurred during a joint group meeting of the Chinese People’s Political Consultative Conference (CPPCC), has ignited renewed determination among health experts and policymakers to achieve the ambitious ‘Healthy China 2035’ vision.

President Xi emphasized that the forthcoming 15th Five-Year Plan period (2026-2030) represents a critical phase for establishing decisive progress toward nationwide health objectives. His address to advisers from the medical, health, welfare, and social security sectors highlighted the strategic importance of coordinated planning and rapid implementation.

Professor Jiang Jiandong, a CPPCC member and pharmaceutical sciences expert at the Chinese Academy of Medical Sciences, described the meeting as both inspirational and demanding. “President Xi’s profound concern for public health left a deep impression,” Jiang stated, outlining his commitment to developing a comprehensive pharmaceutical innovation ecosystem spanning from foundational research to clinical applications and commercial distribution.

The convergence of artificial intelligence with medical science emerged as a recurring theme. Jiang advocated for combining AI capabilities with biological intelligence to enhance drug design and data analysis while mitigating algorithmic limitations. This dual approach aims to advance treatments for cancer, metabolic diseases, and central nervous system disorders.

CPPCC member Wang Lu highlighted practical measures to bridge urban-rural health disparities, noting China’s current average life expectancy of 79.2 years and the target of reaching 80 years by 2030. Wang proposed expanding AI-assisted diagnostic platforms to empower rural clinics, potentially increasing their treatment capacity from several hundred to over 2,000 conditions while improving accuracy.

Innovative solutions for grassroots healthcare received significant attention. Ma Xiuzhen, a political advisory leader from Ningxia, proposed providing every resident with an AI-powered ‘intelligent family doctor’ at an estimated annual cost of less than 50 yuan per person. This digital solution would handle routine consultations, facilitate disease screening, and alleviate pressure on overworked community physicians.

The National Health Commission reported encouraging progress in primary care, with grassroots institutions handling 52.6% of all medical visits in 2025—a steadily increasing share that reflects improvements in tiered diagnosis systems.

The meeting also featured specialized contributions, including altitude sickness research from Xizang autonomous region expert Pasang Drolma, who reported successful prevention of altitude-related fatalities among workers on major infrastructure projects like the Qinghai-Xizang Railway. She expressed particular motivation from Xi’s emphasis on integrating traditional Chinese medicine with modern medical science.